Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan D'Andrea

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Nature Reviews. Cancer|May 31, 2020
Tumour predisposition and cancer syndromes as models to study gene-environment interactionsMichele Carbone, Sarah T Arron, Bruce Beutler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2020
TBCRC 048: Phase II Study of Olaparib for Metastatic Breast Cancer and Mutations in Homologous Recombination-Related GenesNadine M Tung, Mark E Robson, Steffen Ventz, et al.
JAMA Oncology|June 14, 2019
Single-Arm Phases 1 and 2 Trial of Niraparib in Combination With Pembrolizumab in Patients With Recurrent Platinum-Resistant Ovarian CarcinomaPanagiotis A Konstantinopoulos, Steven Waggoner, Gregory A Vidal, et al.
Research Square|April 22, 2024
Increased frequency of CHD1 deletions in prostate cancers of African American men is associated with rapid disease progression without inducing homologous recombination deficiencyZoltan Szallasi, Miklos Diossy, Viktoria Tisza, et al.
Cancer Cell|April 20, 2005
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosisRoss L Levine, Martha Wadleigh, Jan Cools, et al.
Blood Advances|May 2, 2022
Metformin for treatment of cytopenias in children and young adults with Fanconi anemiaJessica A Pollard, Elissa Furutani, Shanshan Liu, et al.
Cancer Discovery|August 7, 2014
Somatic ERCC2 mutations correlate with cisplatin sensitivity in muscle-invasive urothelial carcinomaEliezer M Van Allen, Kent W Mouw, Philip Kim, et al.
Nature|April 12, 2019
WRN helicase is a synthetic lethal target in microsatellite unstable cancersEdmond M Chan, Tsukasa Shibue, James M McFarland, et al.
The Journal of Clinical Investigation|September 5, 2018
Immunogenomic analyses associate immunological alterations with mismatch repair defects in prostate cancerDaniel Nava Rodrigues, Pasquale Rescigno, David Liu, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Nature Reviews. Cancer|May 31, 2020
Tumour predisposition and cancer syndromes as models to study gene-environment interactionsMichele Carbone, Sarah T Arron, Bruce Beutler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2020
TBCRC 048: Phase II Study of Olaparib for Metastatic Breast Cancer and Mutations in Homologous Recombination-Related GenesNadine M Tung, Mark E Robson, Steffen Ventz, et al.
JAMA Oncology|June 14, 2019
Single-Arm Phases 1 and 2 Trial of Niraparib in Combination With Pembrolizumab in Patients With Recurrent Platinum-Resistant Ovarian CarcinomaPanagiotis A Konstantinopoulos, Steven Waggoner, Gregory A Vidal, et al.
Research Square|April 22, 2024
Increased frequency of CHD1 deletions in prostate cancers of African American men is associated with rapid disease progression without inducing homologous recombination deficiencyZoltan Szallasi, Miklos Diossy, Viktoria Tisza, et al.
Cancer Cell|April 20, 2005
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosisRoss L Levine, Martha Wadleigh, Jan Cools, et al.
Blood Advances|May 2, 2022
Metformin for treatment of cytopenias in children and young adults with Fanconi anemiaJessica A Pollard, Elissa Furutani, Shanshan Liu, et al.
Cancer Discovery|August 7, 2014
Somatic ERCC2 mutations correlate with cisplatin sensitivity in muscle-invasive urothelial carcinomaEliezer M Van Allen, Kent W Mouw, Philip Kim, et al.
Nature|April 12, 2019
WRN helicase is a synthetic lethal target in microsatellite unstable cancersEdmond M Chan, Tsukasa Shibue, James M McFarland, et al.
The Journal of Clinical Investigation|September 5, 2018
Immunogenomic analyses associate immunological alterations with mismatch repair defects in prostate cancerDaniel Nava Rodrigues, Pasquale Rescigno, David Liu, et al.
Pageof 4